Medicure Inc. (OTCMKTS:MCUJF) Sees Large Growth in Short Interest

Medicure Inc. (OTCMKTS:MCUJFGet Free Report) was the target of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 1,500 shares, an increase of 650.0% from the February 28th total of 200 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average trading volume of 6,900 shares, the short-interest ratio is currently 0.2 days.

Medicure Stock Performance

Shares of MCUJF stock remained flat at $0.46 during mid-day trading on Thursday. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.03 and a quick ratio of 1.64. Medicure has a 1 year low of $0.46 and a 1 year high of $0.92. The firm has a market cap of $4.75 million, a PE ratio of -3.25 and a beta of 0.87. The business’s fifty day moving average price is $0.52 and its 200-day moving average price is $0.62.

Medicure Company Profile

(Get Free Report)

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.

Further Reading

Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.